Tramazoline: Difference between revisions
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
m Protected "Tramazoline": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
(3 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| IUPAC_name | | Verifiedfields = changed | ||
| image | | Watchedfields = changed | ||
| verifiedrevid = 457287903 | |||
| IUPAC_name = ''N''-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5-dihydro-1''H''-imidazol-2-amine | |||
| | | image = Tramazoline.png | ||
| | |||
<!--Clinical data--> | |||
| tradename = | |||
| Drugs.com = {{drugs.com|international|tramazoline}} | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | |||
| | | pregnancy_US = <!-- A / B / C / D / X --> | ||
| | | pregnancy_category = | ||
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> | |||
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> | |||
| pregnancy_AU | | legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> | ||
| pregnancy_US | | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | ||
| pregnancy_category= | | legal_status = | ||
| legal_AU | | routes_of_administration = | ||
| legal_CA | |||
| legal_UK | <!--Pharmacokinetic data--> | ||
| legal_US | | bioavailability = | ||
| legal_status | | protein_bound = | ||
| routes_of_administration = | | metabolism = | ||
| elimination_half-life = | |||
| excretion = | |||
<!--Identifiers--> | |||
| CAS_number_Ref = {{cascite|changed|??}} | |||
| CAS_number = 1082-57-1 | |||
| ATC_prefix = R01 | |||
| ATC_suffix = AA09 | |||
| PubChem = 5524 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = SLE31693IV | |||
| ChEMBL_Ref = {{ebicite|changed|EBI}} | |||
| ChEMBL = 32573 | |||
<!--Chemical data--> | |||
| C=13 | H=17 | N=3 | |||
| molecular_weight = 215.294 g/mol | |||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''Tramazoline''' is a chemical that is used in the form of '''tramazoline hydrochloride''' in nasal decongestant preparations. <ref>{{cite web|first=Boehringer Ingelheim|title=Spray-Tish Consumer Information|url=http://www.mydr.com.au/medicines/cmis/spray-tish-nasal-spray|work=Consumer Medicines Information|publisher=MyDr.com.au|accessdate=16 April 2011}}</ref> It is an α-adrenergic receptor agonist that inhibits secretion of nasal mucus. | |||
It causes [[hypertension]].<ref name="pmid7721439">{{cite journal |author=Peng N, Meng QC, King K, Oparil S, Wyss JM |title=Acute hypertension increases norepinephrine release in the anterior hypothalamic area |journal=Hypertension |volume=25 |issue=4 Pt 2 |pages=828–33 |date=April 1995 |pmid=7721439 |doi= 10.1161/01.hyp.25.4.828|url=http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=7721439}}</ref> | |||
==References== | |||
{{reflist|2}} | |||
{{Nasal preparations}} | {{Nasal preparations}} | ||
[[Category:Imidazolines]] | [[Category:Imidazolines]] | ||
[[Category:Drug]] | |||
Latest revision as of 17:19, 20 August 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C13H17N3 |
Molar mass | 215.294 g/mol |
(what is this?) (verify) |
WikiDoc Resources for Tramazoline |
Articles |
---|
Most recent articles on Tramazoline Most cited articles on Tramazoline |
Media |
Powerpoint slides on Tramazoline |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Tramazoline at Clinical Trials.gov Clinical Trials on Tramazoline at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Tramazoline
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Tramazoline Discussion groups on Tramazoline Patient Handouts on Tramazoline Directions to Hospitals Treating Tramazoline Risk calculators and risk factors for Tramazoline
|
Healthcare Provider Resources |
Causes & Risk Factors for Tramazoline |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tramazoline is a chemical that is used in the form of tramazoline hydrochloride in nasal decongestant preparations. [1] It is an α-adrenergic receptor agonist that inhibits secretion of nasal mucus.
It causes hypertension.[2]
References
- ↑ "Spray-Tish Consumer Information". Consumer Medicines Information. MyDr.com.au. Retrieved 16 April 2011.
|first1=
missing|last1=
in Authors list (help) - ↑ Peng N, Meng QC, King K, Oparil S, Wyss JM (April 1995). "Acute hypertension increases norepinephrine release in the anterior hypothalamic area". Hypertension. 25 (4 Pt 2): 828–33. doi:10.1161/01.hyp.25.4.828. PMID 7721439.
- Pages with script errors
- CS1 errors: missing author or editor
- CS1 maint: Multiple names: authors list
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Imidazolines
- Drug